Otsuka Pharmaceutical Development & Commercialization, Inc.

This early-stage study aims to understand how the body absorbs, breaks down, and eliminates a potential new oral medication for schizophrenia. Eight healthy adult men will receive a single dose containing a tiny, safe amount of radioactive tracer to track the drug's path. The mai…

This early-stage study aims to see how a new drug called repinatrabit interacts with several common medications, including birth control, diabetes, and cholesterol drugs. It will involve 48 healthy volunteers to measure drug levels in the blood and check for safety. The goal is t…